Escolar Documentos
Profissional Documentos
Cultura Documentos
Classification
1. i. COX 1 and 2 inhibitors: Analgesic and antiinflammatory
Salicylates: Aspirin and other salicylates. Acetic acid derivatives: Indomethacin, diclofenac, Ketorolac Propionic acid derivatives: Ibuprofen, Naproxen. Fenamic acid derivatives: Mefenamic acid, Enolic acid derivatives: Piroxicam
ii.
2.
COX-2 inhibitors: Celecoxib, etoricoxib, meloxicam(preferential COX2 inhiibitor) Dont affect platelets, efficacy equals to older NSAIDs; GIT safety improved but they may inc. hypertension, edema
COX-1 constitutive, present in most tissues: GIT (cytoprotective), kidney (vasodilatation), platelets (controls platelet aggregation, PGI2 inhibits &TxA2 increases) involved in tissue homeostasis.
COX-2 is induced in inflammatory cells by cytokines & endotoxins- produce prostanoids. It is constitutive in brain, kidney. Infection or immune reaction release IL-1 & TNF induction of COX-2 in inflammatory cells PG formation Role of PGs in inflammation: Vasodilatation: redness. Inc. capillary permeability: edema formation-swelling Infection/inflammation IL-1 release from macrophages inc. PGE2 in hypothalamus inc set point of hypothalamic temperature regulating centre increase heat production fever
NSAIDs
Mechanism of action They act by inhibition of cyclooxygenase responsible for the formation of prostaglandins. Most NSAIDs inhibit both COX1 and 2. Some NSAIDs are selective COX2 inhibitors. Aspirin irreversibly acetylates and blocks cyclooxygenase (COX 1& 2) Other NSAIDs are reversible inhibitors. Additional mechanisms: Inhibition of lipooxygenase by indomethacin & declofenac . Also inhibition of leucocyte migration & superoxide formation. Down regulation of IL-1 production Interference with calcium mediated intracellular events Decrease the sensitivity of vessels to bradykinin & histamine,
Antipyretic action : Mechanism NSAIDs inhibit production of PGE2 in the hypothalamus . Rapidly reduce elevated body temperature in patients with fever, but no effect in normal person. It resets the hypothalamic thermostat to normal
NSAIDs: Common unwanted 1. GI disturbances: Commonest- particularly in elderly patients. effects abdominal pain, diarrhoea sometimes constipation, nausea and vomiting. Dyspepsia,
Gastric damage, ulcer, which may be silent but carries a definite risk of serious haemorrhage and or perforation. Highest incidence of bleeding with piroxicam, less bleeding with diclofenac and naproxen, least risk with ibuprofen. 2. Skin reactions 2nd most common adverse effect particularly with mefenamic acid. Skin rashes all types, pruritus, urticaria, photosensitivity to severe fatal conditions. 3. Renal effects: Acute renal insufficiency : more with indomethacin. Retention of salt and water and edema formation in some (inh. of PG). Chronic analgesic use: can cause analgesic nephropathy (chronic nephritis and renal papillary necrosis). 4. 5. 6. 7. 8. CNS: headache, tinnitus, dizziness CVS: fluid retention, hypertension, edema, CHF Pulmonary: asthma Liver disorders: abnormal liver functions; overdose of paracetamol causes liver failure. Rare: Hematological: thrombocytopenia, neutropenia and even aplastic anemia- indomethacin
iii.
Uncoupling of oxidative phosphorylation increased cellular metabolism-increased CO2 production- inc resp. Inc utilisation of glucose, blood sugar may dec.esp.in diabetics. Hyperglycemia seen at toxic doses due to central sympathetic stimulation and release of adrenaline and corticosteroids.
5.
At antiinflammatory dose respirations are stimulated: direct stimulation of RC and also through peripheral effects, i.e, inc CO2 production, stimulate resp centre hyperventilation. Further inc. in salicylate conc.resp. depression.
Effect on Blood: Platelet: In small doses (81-325mg)irreversibly acetylates and inhibits COX-1 & synthesis of TXA2 by platelets. Platelets have no capacity to synthesise protein, hence effect lasts for life of platelet (7-8D)
Interferes with platelet aggregation and bleeding time is prolonged. Effect lasts a week (turnover time of platelets). ii. Prothrombin time:
Long term use of large doses dec. synthesis of clotting factors in liver can be prevented by prophylactic vitamin K.
Mechanism: All NSAIDs inhibit PG synthesis. PGs inhibit gastric acid secretion, inc.mucus production and act as cytoprotective for gastric mucosa. Thus aspirin enhances aggressive factors ulcerogenic.
Pharmacokinetics: Aspirin
Absorption From stomach and small intestine.. Distribution 80% bound to plasma proteins, enters brain, crosses placenta. Displacement interaction may occur Metabolism Rapidly deacetylated by esterases in the gut wall, liver, plasma and other tissues to release salicylic acid - the major circulating and active form. Both aspirin and salicylic acid are conjugated in liver to glycine (75%) salicyluric acid (major pathway- rate limiting); and glucuronic acid (15%). Little oxidised 1% genitisic acid. Metabolites are excreted by GF and TS. Normally 10%is excreted as free salicylic acid- but this can be increased by alkalinization of urine. Half life: dose dependent metabolism. Aspirin: 15-20 minutes, salicylic acid - 3-5 hours. At higher doses- 15 to 30 hours. Preparations: tablets: plain, buffered, soluble effervescent, enteric coated, sustained release
Adverse effects
i. GI effects:
Nausea, vomiting, epigastric distress, increased occult blood loss in stools. Profuse gastric hemorrhage- idiosyncratic response. Aspirin and all NSAIDs: gastric mucosal damage and peptic ulceration.
CNS effects with higher (Antiinflammatory) doses (3-6g/d): chronic moderate toxicity-salicylism: tinnitus, hearing difficulty, dizziness, headache, mental confusion. Hepatic toxicity: Aspirin- Reye's syndrome (a rare form of hepatic encephalopathy)- seen in children with viral (varicella,influenza) infection. Dose dependent- hepatotoxicity- more in patients with connective tissue diseases- inc transaminases Allergy or pseudoallergy and idiosyncrasy Rashes,urticaria, rhinitis, angioedema, asthma and shock- those who already suffer from urticaria, nasal polyps or asthma are more susceptible- pseudoallergic reaction.
Salicylate toxicity
Conc. ( g/ml) Effects Complications
Up to 10 Analgesic, antipyretic, antiplatelet 10-40 50 50-80 80-110 Mild intoxication Moderate Antiinflammatory, uricosuric
Contraindications/cautions: aspirin
Contraindications:
Patients who are sensitive. Patients with hemophilia. Patients with peptic ulcer, bleeding tendencies Children suffering from chicken pox or influenza due to risk of Reye's syndrome. Patients with chronic liver disease - hepatic necrosis may occur.
Cautions:
Avoided in patients with diabetes, diminished cardiac reserve or frank CHF, and juvenile rheumatoid arthritis. Should be stopped one week prior to any surgery. Given during pregnancy- low birth babies. Taken at term: delayed and prolonged labor, greater postpartum blood loss and premature closure of ductus arteriosus. It should be avoided by nursing mothers. Bronchial asthma Gout
Uses: aspirin
To decrease incidence of TIA (transient ischemic attacks), unstable angina, coronary artery thrombosis & myocardial infarction and thrombosis after coronary bypass graft, in postmyocardial infarction and post stroke patients: low dose aspirin: 81 mg/d Reduces the risk of cancer of colon and possibly also rectal cancer. As analgesic: Nonvisceral pain of mild to moderate severity. E.g. effective in headache, myalgia, joint pain, toothache, neuralgia,and dysmenorrhoea. With opioids for cancer pain As antipyretic- It is effective in fever of any origin; dose is same as for analgesia Acute rheumatic fever: drug of first choice Rheumatoid arthritis: Large doses not tolerated, NSAIDs are often used. Osteoarthritis. Other uses of aspirin: Pregnancy associated hypertension and preeclampsia: PDA: for closure, indomethacin is preferred. Radiation sickness diarrhoea: PGs probably are involved, aspirin reduces stool volume.
Drug
Indomethacin Diclofenac
2 2
+ + +
+ + +
+ ++ +
45 42-98 2-4 + + Safe and effective mild analgesic in therapeutic doses. Less analgesic efficacy in inflammatory conditions. Chronic use can cause kidney damage. Over dose causes serious hepatotoxicity.
Acetaminophen (paracetamol)
A metabolite of phenacetin. Central analgesic effect: Acts on COX-3 Antipyretic. It has no antiinflammatory activity. No effect on respiration, acid base balance; cellular metabolism. Gastric irritation is insignificant and mucosal erosion and bleeding occur rarely only in overdose. It doesn't alter platelet function or clotting factors. It is not uricosuric. ADME: Abs. well, 33% protein bound distributed in the body. Conjugated with glucuronic acid (60%) and sulphate (35%) and partly hydroxylated (NAPQI- epoxide which conjugates with glutathione to form mercapturate), rapidly excreted in urine. Plasma half life- 2-3 hours.
Acetaminophen
Adverse effects:
Click to edit Master text style Second level Rashes, nausea, and leucopenia is rare. Third level Analgesic nephropathy- chronic use- mainly phenacetin but others might also produce this condition. Fourth level Acute paracetamol poisoning- hepatotoxicity, renal Fifth level
toxicity Mechanism of toxicity N acetyl-benzoquinone-imine is a highly reactive metabolite detoxified by conjugation with glutathione. With large dose , hepatic glutathione is depleted and this metabolite oxidses SH containing enzymes and proteins and causes cellular damage ( and renal tubules) causing necrosis. In chronic alcoholics small dose ( 5-6 gram/day) taken for a few days may produce hepatotoxicity. Treatment: N-acetylcysteine. It is practically ineffective if started 16 hours or more after paracetamol ingestion. Uses: As analgesic , Antipyretic.
More prone to produce GI upset. C/I in Less GI side effects, no contraindicated in peptic ulcer patient peptic ulcer patients Produces metabolic effects No such effects Produces acid base disturbances in overdose Less so in acute toxicity Hypersensitivity reactions are common Significant drug interactions Less incidence of hypersensitivity reactions Not so
Acid base and electrolyte abnormailities inHepatotoxicity in acute overdosage acute overdosage
Meloxicam
Related to piroxicam Preferentially inhibits COX-2 over COX 1 at low dose. Has less GI symptoms than piroxicam and diclofenac Inhibits TXA2